Filter

Refine by collections

  • Cardiovascular (8)

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 8 of 8 items for :

  • hormone therapy x
  • Cardiovascular x
Clear All
Charlotte Höybye Department of Endocrinology and Department of Molecular Medicine and Surgery, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden

Search for other papers by Charlotte Höybye in
Google Scholar
PubMed Close
,
Beverly M K Biller Neuroendocrine Unit, Massachusetts General Hospital, Massachusetts General Hospital, Boston, Massachusetts, USA

Search for other papers by Beverly M K Biller in
Google Scholar
PubMed Close
,
Jean-Marc Ferran Qualiance ApS, Copenhagen, Denmark

Search for other papers by Jean-Marc Ferran in
Google Scholar
PubMed Close
,
Murray B Gordon Allegheny Neuroendocrinology Center, Division of Endocrinology, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA

Search for other papers by Murray B Gordon in
Google Scholar
PubMed Close
,
Nicky Kelepouris US Medical Affairs-Rare Endocrine Disorders, Novo Nordisk, Inc, Plainsboro, New Jersey, USA

Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed Close
,
Navid Nedjatian Global Medical Affairs – Rare Endocrine Disorders, Novo Nordisk Health Care AG, Zurich, Switzerland

Search for other papers by Navid Nedjatian in
Google Scholar
PubMed Close
,
Anne H Olsen Epidemiology, Novo Nordisk A/S, Soborg, Denmark

Search for other papers by Anne H Olsen in
Google Scholar
PubMed Close
, and
Matthias M Weber Unit of Endocrinology, 1, Medical Department, University Hospital, Universitätsmedizin Mainz, der Johannes Gutenberg-Universität, Mainz, Germany

Search for other papers by Matthias M Weber in
Google Scholar
PubMed Close

quality of life, an adverse lipid profile and an increased risk for cardiovascular (CV)-associated disease, diabetes and metabolic syndrome vs healthy adults ( 4 , 5 , 6 , 7 ). The use of growth hormone (GH) replacement therapy in AGHD has been shown

Article Type:
Research Article
Collections:
Cardiovascular
DOI:
https://doi.org/10.1530/EC-22-0267
Volume/Issue:
Volume 12: Issue 1
Open access
Alicia Romano Department of Pediatrics, New York Medical College, Valhalla, New York, USA

Search for other papers by Alicia Romano in
Google Scholar
PubMed Close
,
Juan Pablo Kaski Centre for Inherited Cardiovascular Diseases, Great Ormond Street Hospital & UCL Institute of Cardiovascular Science, London, UK

Search for other papers by Juan Pablo Kaski in
Google Scholar
PubMed Close
,
Jovanna Dahlgren Department of Paediatrics, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Jovanna Dahlgren in
Google Scholar
PubMed Close
,
Nicky Kelepouris US Medical Affairs, Novo Nordisk Inc., Plainsboro, New Jersey, USA

Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed Close
,
Alberto Pietropoli Global Medical Affairs, Novo Nordisk Health Care AG, Zurich, Switzerland

Search for other papers by Alberto Pietropoli in
Google Scholar
PubMed Close
,
Tilman R Rohrer Department of Pediatric Endocrinology, University Children’s Hospital, Saarland University Medical Center, Homburg, Germany

Search for other papers by Tilman R Rohrer in
Google Scholar
PubMed Close
, and
Michel Polak Paediatric Endocrinology, Diabetology and Gynaecology Department, Hôpital Universitaire Necker Enfants-Malades, AP-HP, Université de Paris, Imagine Institute, Paris, France

Search for other papers by Michel Polak in
Google Scholar
PubMed Close

://doi.org/10.1159/000048101 ) 9 MacFarlane CE Brown DC Johnston LB Patton MA Dunger DB Savage MO McKenna WJ Kelnar CJ . Growth hormone therapy and growth in children with Noonan’s syndrome: results of 3 years’ follow-up . Journal of Clinical

Article Type:
Research Article
Collections:
Cardiovascular
DOI:
https://doi.org/10.1530/EC-21-0549
Volume/Issue:
Volume 11: Issue 1
Open access
Agata Hanna Bryk-Wiązania Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland

Search for other papers by Agata Hanna Bryk-Wiązania in
Google Scholar
PubMed Close
,
Mari Minasyan Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland

Search for other papers by Mari Minasyan in
Google Scholar
PubMed Close
,
Alicja Hubalewska-Dydejczyk Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland

Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed Close
, and
Aleksandra Gilis-Januszewska Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland

Search for other papers by Aleksandra Gilis-Januszewska in
Google Scholar
PubMed Close

to achieve remission. One patient started medical therapy due to severe ectopic adrenocorticotropic hormone (ACTH) syndrome and experienced fatal PE. Characteristic n (%) Type of treatment  TSS + steroidogenesis

Article Type:
Research Article
Collections:
Cardiovascular
DOI:
https://doi.org/10.1530/EC-23-0557
Volume/Issue:
Volume 13: Issue 9
Open access
Eng-Loon Tng Department of Medicine, Level 8, Tower A, Ng Teng Fong General Hospital, Singapore

Search for other papers by Eng-Loon Tng in
Google Scholar
PubMed Close
,
Yee Sian Tiong Department of Medicine, Level 8, Tower A, Ng Teng Fong General Hospital, Singapore

Search for other papers by Yee Sian Tiong in
Google Scholar
PubMed Close
,
Aye Thida Aung Department of Medicine, Level 8, Tower A, Ng Teng Fong General Hospital, Singapore

Search for other papers by Aye Thida Aung in
Google Scholar
PubMed Close
,
Nicole Ya Yuan Chong Department of Medicine, National University Hospital, Singapore

Search for other papers by Nicole Ya Yuan Chong in
Google Scholar
PubMed Close
, and
Zhemin Wang Department of Medicine, National University Hospital, Singapore

Search for other papers by Zhemin Wang in
Google Scholar
PubMed Close

Interventional and observational studies reporting the efficacy and safety of anticoagulation, antiplatelet therapy, or no therapy in people with TAF were eligible for inclusion. Interventional studies include non-randomized studies and RCTs. Observational

Article Type:
Research Article
Collections:
Cardiovascular
DOI:
https://doi.org/10.1530/EC-22-0166
Volume/Issue:
Volume 11: Issue 5
Open access
Shenghe Luo College of Pharmacy, Yanbian University, Yanji, China

Search for other papers by Shenghe Luo in
Google Scholar
PubMed Close
,
Yunhui Zuo Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji, China
Department of Cardiology, Yanbian University Hospital, Yanji, China

Search for other papers by Yunhui Zuo in
Google Scholar
PubMed Close
,
Xiaotian Cui Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji, China

Search for other papers by Xiaotian Cui in
Google Scholar
PubMed Close
,
Meiping Zhang Department of Cardiology, Yanbian University Hospital, Yanji, China

Search for other papers by Meiping Zhang in
Google Scholar
PubMed Close
,
Honghua Jin Department of Pharmacy, Yanbian University Hospital, Yanji, China

Search for other papers by Honghua Jin in
Google Scholar
PubMed Close
, and
Lan Hong Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji, China

Search for other papers by Lan Hong in
Google Scholar
PubMed Close

widely used in the clinic as second-line therapy for type II diabetes, and GLP-1R agonists have been used in the clinical treatment of obesity in countries such as Korea and the United States ( 3 , 4 , 5 ). GLP-1R is expressed in many tissues, including

Article Type:
Research Article
Collections:
Cardiovascular
DOI:
https://doi.org/10.1530/EC-23-0176
Volume/Issue:
Volume 12: Issue 11
Open access
Anne-Sophie C A M Koning Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

Search for other papers by Anne-Sophie C A M Koning in
Google Scholar
PubMed Close
,
Philippe C Habets Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

Search for other papers by Philippe C Habets in
Google Scholar
PubMed Close
,
Marit Bogaards Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

Search for other papers by Marit Bogaards in
Google Scholar
PubMed Close
,
Jan Kroon Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

Search for other papers by Jan Kroon in
Google Scholar
PubMed Close
,
Hanneke M van Santen Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Pediatric Neuro-Oncology, Prinses Máxima Centrum, Utrecht, The Netherlands

Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed Close
,
Judith M de Bont Department of Pediatric Neuro-Oncology, Prinses Máxima Centrum, Utrecht, The Netherlands

Search for other papers by Judith M de Bont in
Google Scholar
PubMed Close
, and
Onno C Meijer Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

Search for other papers by Onno C Meijer in
Google Scholar
PubMed Close

study the biological mechanisms of action that underlie them, and this might help to decrease these adverse effects during glucocorticoid therapy. Synthetic glucocorticoids target the glucocorticoid receptor (GR), one of the two receptor types for the

Article Type:
Research Article
Collections:
Cardiovascular
DOI:
https://doi.org/10.1530/EC-21-0425
Volume/Issue:
Volume 11: Issue 3
Open access
Simon Chang Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Internal Medicine, Lillebaelt Hospital, Kolding, Denmark

Search for other papers by Simon Chang in
Google Scholar
PubMed Close
,
Arkadiusz J Goszczak NanoSYD, The Mads Clausen Institute, University of Southern Denmark, Sønderborg, Denmark

Search for other papers by Arkadiusz J Goszczak in
Google Scholar
PubMed Close
,
Anne Skakkebæk Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Anne Skakkebæk in
Google Scholar
PubMed Close
,
Jens Fedder Centre of Andrology and Fertility Clinic, Odense University Hospital, Odense, Denmark

Search for other papers by Jens Fedder in
Google Scholar
PubMed Close
,
Anders Bojesen Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Anders Bojesen in
Google Scholar
PubMed Close
,
M Vakur Bor Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark

Search for other papers by M Vakur Bor in
Google Scholar
PubMed Close
,
Moniek P M de Maat Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark
Department of Haematology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands

Search for other papers by Moniek P M de Maat in
Google Scholar
PubMed Close
,
Claus H Gravholt Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Claus H Gravholt in
Google Scholar
PubMed Close
, and
Anna-Marie B Münster Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark

Search for other papers by Anna-Marie B Münster in
Google Scholar
PubMed Close

criteria included prior thrombosis, current anticoagulation therapy or use of platelet inhibitors, current use of narcotics, diabetes mellitus, and prior severe head trauma. Male controls with total testosterone levels below the assay reference were

Article Type:
Research Article
Collections:
Cardiovascular
DOI:
https://doi.org/10.1530/EC-21-0490
Volume/Issue:
Volume 11: Issue 5
Open access
Ying-Lien Cheng Division of Endocrinology and Metabolism, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan

Search for other papers by Ying-Lien Cheng in
Google Scholar
PubMed Close
,
Ting-I Lee Division of Endocrinology and Metabolism, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

Search for other papers by Ting-I Lee in
Google Scholar
PubMed Close
,
Yu-Mei Chien Division of Endocrinology and Metabolism, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan

Search for other papers by Yu-Mei Chien in
Google Scholar
PubMed Close
,
Ting-Wei Lee Division of Endocrinology and Metabolism, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

Search for other papers by Ting-Wei Lee in
Google Scholar
PubMed Close
, and
Yi-Jen Chen Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Cardiovascular Research Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan

Search for other papers by Yi-Jen Chen in
Google Scholar
PubMed Close

supplementation may be considered as an adjunct therapy in patients with hypertriglyceridemia and concomitant vitamin D deficiency in clinical practice. Age and sex modulate the association between increased serum 25(OH)D and lipid levels Vitamin D

Article Type:
Research Article
Collections:
Cardiovascular
DOI:
https://doi.org/10.1530/EC-23-0013
Volume/Issue:
Volume 12: Issue 9
Open access